Table 8. Summary of implicated miRNAs and their targeted pathways from Sjögren’s syndrome and dry eye disease studies.
| Study | Disease | Exosomal miRNA | Targeted Pathway |
|---|---|---|---|
| Xing et al. 2022 |
SS | miR−125b | Suppression of PRDM1 regulated B cell differentiation |
| Zhao et al. 2023 |
SS | miR−125b | M2-M1 macrophages imbalance, thereby affecting Th17 cells |
| Kim et al. 2021 |
SS | miR−125b | M2-M1 macrophages imbalance, Th1 and Th17 cytokines |
| Wang et al. 2023 | DED | miR−125b | Downregulation of NF-κB |
| Kim et al. 2021 |
SS | miR−21−5p | Inhibits secretion of IL−6, IFN-γ and IL−17 |
| Wang et al. 2023 | DED | miR−6873 | Downregulation of NF-κB |
| Li et al. 2022 |
SS | miR−100−5p | Increased polarisation of macrophages from M1 to M2 phenotype |
| Zhou et al. 2023 |
SS | miR−10A−5p | Inhibits Bcl−6 and B cell differentiation |